Medical International Technologies Gets Approval for its Needle-Free Injection Technology from the Japanese MAFF.

DENVER -- Medical International Technology, Inc. (OTCBB:MDIR), a developer and marketer of patented needle-free jet injectors for human and animal inoculation, today announced that on September 15th, 2004, the Japanese Ministry of Agriculture, Fishery and Forestry (MAFF) has endorsed its needle-free injection technology and has granted MIT's Japanese Distributor "Frontier International Co. Ltd" permission to market and sell freely MIT's AGRO-JET needle-free injectors in Japan. The AGRO-JET line of needle-free injectors is manufactured by MIT Canada (a subsidiary of Medical International Technology, Inc.)

Frontier International had initially signed a 3-year agreement with MIT in September 2003, valued at $1.2 million for the distribution of the AGRO-JET. However, due to new regulations imposed by MAFF in January 2004 on new technology imports, it was forced to suspend the sales pending clearance from MAFF and the issuance of an official import permit. In anticipation for that permit, Frontier had placed a large order for the AGRO-JET last June with predetermined deliveries over the 4th quarter of 2004, the first of which has already been completed on September 16th, 2004. Now, with the official permit on hand, it is expected that Frontier International will resume its purchase schedule as agreed to in the current Distribution Agreement.

"We are all elated at the news as this is a very important and major milestone for MIT given the difficulty to penetrate the Japanese market and the long and tedious process which has lasted 9 months before Frontier International finally obtained the official import permit," said Mr. Menassa, President & CEO of MIT. "The endorsement of MAFF is yet more proof that MIT'S injection technology is gaining acceptance around the world," stated Mr. Menassa.

"The Global poultry and livestock markets (including cattle, swine, sheep, etc.) represent several billion dollars and the potential for MIT's AGRO-JET is huge," Mr. Menassa, added.

MIT CANADA, with offices in Montreal, is a subsidiary of Denver, Colorado-based Medical International Technology, Inc. (MIT USA), which specializes in the development, production, marketing and sale of needle-free injectors both for humans and animals, for individual and mass vaccinations

This press release contains certain "forward-looking" statements, as defined in the U.S. Private Securities Litigation Reform Act of 1995 that involves a number of risks and uncertainties. Statements, which are not historical facts, are forward-looking statements. The Company, through its management, makes forward-looking public statements concerning its expected future operations, performance and other developments. Such forward-looking statements are necessarily estimates reflecting the Company's best judgment based upon current information and involve a number of risks and uncertainties, and there can be no assurance that other factors will not affect the accuracy of such forward-looking statements. It is impossible to identify all such factors, factors that could cause actual results to differ materially from those estimated by the Company. They include, but are not limited to, government regulation, managing and maintaining growth, the effect of adverse publicity, litigation, competition and other factors that may be identified from time to time in the Company's public announcements.